Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Hims & Hers Health Inc
(NY:
HIMS
)
16.10
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Sep 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Hims & Hers Health Inc
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Top 5 Health Care Stocks That May Collapse In February
February 13, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
Why Hims & Hers Health Stock Was so Healthy This Week
February 10, 2023
Investors take an analyst's very positive change in sentiment to heart.
Via
The Motley Fool
MGM Resorts, Madison Square Garden Entertainment, Cardiovascular Systems And Other Big Stocks Moving Higher On Thursday
February 09, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Thursday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 9, 2023
February 09, 2023
Via
Benzinga
Hims & Hers Health's Return on Invested Capital Overview
December 01, 2022
Via
Benzinga
Better Growth Stock: Teladoc vs. Hims & Hers
November 13, 2022
A showdown between two hot telehealth companies.
Via
The Motley Fool
Does This Brain Drink Help You Leave Work Earlier?
December 05, 2022
Interested in investing in TruBrain's campaign? Click here to get started!
Via
Benzinga
5 Stocks That Could Double Your Money in 2023
December 02, 2022
100% gains in this market? It's not as crazy as it sounds.
Via
The Motley Fool
Worried About Amazon? Buy This Fast-Growing Stock Instead
November 23, 2022
Hims & Hers is a small-cap stock that is on track to nearly double its revenue this year.
Via
The Motley Fool
DuPont, Expeditors International, Planet Fitness And Other Big Gainers From Tuesday
November 09, 2022
U.S. stocks closed higher on Tuesday, with the Dow Jones surging more than 300 points. Here is the list of some big stocks recording gains in the previous session.
Via
Benzinga
Why Hims & Hers Health Stock Soared Today
November 08, 2022
Profitability could come sooner than investors expected.
Via
The Motley Fool
Analyst Ratings for Hims & Hers Health
November 08, 2022
Within the last quarter, Hims & Hers Health (NYSE:HIMS) has observed the following analyst ratings:
Via
Benzinga
Where Hims & Hers Health Stands With Analysts
November 08, 2022
Analysts have provided the following ratings for Hims & Hers Health (NYSE:HIMS) within the last quarter:
Via
Benzinga
Why Party City Holdco Shares Tumbled Over 40%; Here Are 98 Biggest Movers From Yesterday
November 09, 2022
Gainers Unique Fabricating, Inc. (NYSE: UFAB) jumped 56.3% to close at $0.8205 on Tuesday. Unique Fabricating posted a Q3 loss of $0.90 per share after the closing bell on Tuesday.
Via
Benzinga
This Stock Could 10X in 5 Years
November 02, 2022
An assessment of the company's prospects reveal an ecouraging outlook.
Via
The Motley Fool
12 Health Care Stocks Moving In Tuesday's Intraday Session
November 08, 2022
Gainers
Via
Benzinga
Why TaskUs Shares Are Trading Higher By 37%? Here Are 77 Stocks Moving In Tuesday's Mid-Day Session
November 08, 2022
Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 39.4% to $1.4529 after the company announced a payment assignment from the Centers for Medicare & Medicaid Services for the ProSense breast...
Via
Benzinga
Party City (PRTY) Stock Plunges After a Spooky Halloween
November 08, 2022
Party City (PRTY) stock isn't doing so hot on Tuesday after posting results from its Halloween quarter and 2022 cutting guidance.
Via
InvestorPlace
Why Is Hims & Hers (HIMS) Stock Up 24% Today?
November 08, 2022
Hims & Hers (HIMS) stock is climbing higher on Tuesday after reporting results for the third quarter of 2022 and increasing guidance.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2022
November 08, 2022
Upgrades
Via
Benzinga
SolarEdge Technologies, LivePerson, TaskUs And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
November 08, 2022
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
November 08, 2022
We're starting off the day with a look at the biggest pre-market stock movers traders need to know about on Tuesday morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 08, 2022
Gainers NeuroBo Pharmaceuticals (NASDAQ:NRBO) shares rose 49.1% to $3.22 during Tuesday's pre-market session. The company's market cap stands at $2.8 million.
Via
Benzinga
Why TripAdvisor Shares Are Trading Sharply Lower; Here Are 29 Stocks Moving Premarket
November 08, 2022
Gainers
Via
Benzinga
Earnings Preview For Hims & Hers Health
November 04, 2022
Hims & Hers Health (NYSE:HIMS) is set to give its latest quarterly earnings report on Monday, 2022-11-07. Here's what investors need to know before the announcement. Analysts estimate that Hims & Hers...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 17, 2022
October 17, 2022
Upgrades
Via
Benzinga
What 4 Analyst Ratings Have To Say About Hims & Hers Health
October 17, 2022
Over the past 3 months, 4 analysts have published their opinion on Hims & Hers Health (NYSE:HIMS) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
What 4 Analyst Ratings Have To Say About Hims & Hers Health
September 07, 2022
Over the past 3 months, 4 analysts have published their opinion on Hims & Hers Health (NYSE:HIMS) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022
September 07, 2022
Upgrades
Via
Benzinga
Hims & Hers Health's Return on Invested Capital Overview
August 31, 2022
Benzinga Pro data, Hims & Hers Health (NYSE:HIMS) reported Q2 sales of $113.56 million. Earnings fell to a loss of $19.68 million, resulting in a 21.09% decrease from last quarter.
Via
Benzinga
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.